Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Collaboration needed for strengthening medical research in Europe

06.02.2008
Public spending on medical research in Europe should be doubled over the next ten years to ensure health and welfare for Europe’s citizens and to nurture a thriving European medical research industry. There should be greater collaboration between European institutions in medical research and improved career paths for medical scientists.

These are some of the main recommendations of the European Medical Research Councils (EMRC) White Paper, ‘Present Status and Future Strategy for Medical Research in Europe’ which was debated at a meeting on 30 January 2008 in Frankfurt (Germany) with the participation of the Heads of Medical Research Councils in Europe, Editors of Medical Journals, Presidents of Medical Learned Societies and Deans of Medical Faculties in Europe.

The audience acclaimed the White paper and made the following recommendations:

Increased funding must be by sustainable growth,

Collaboration on big programmes is essential,

Research areas should be determined by health priorities and not only science topics,

Collaboration on an improvement of peer review of grants is essential - and peer reviewers should be acknowledged and rewarded,

MD/PhD programmes are important and should be of high quality,

the best researchers - like the Nobel Laureates at The Lindau meeting - to participate in teaching,

Novel technologies and research infrastructures are important as well as incentive in terms of decent salaries to attract and retain young researchers

To make the White Paper recommendations come true European and global collaboration is needed.

The White Paper is the result of a comprehensive analysis of the current state of medical research within Europe together with an assessment of the new challenges facing Europe’s citizens, with changing patterns of disease, environmental issues as global warming, and changing demographic factors with an ageing population. The paper was launched at a meeting between Janez Potocnik, EU Commissioner for Science and Research, and Professor Liselotte Højgaard, Chair of the European Medical Research Councils in Brussels on 6 December 2007.

The White Paper key recommendations include:

Implementation of best practice for funding and performing medical research – with distribution of funding in competition based on excellence and evaluated by peer review

Strengthened collaboration and coordination of medical research in Europe through the EMRC and its membership organisations, via the European Commission, the European Research Council and the learned medical societies

Revision of EC directives related to medical research

Implementation of equal opportunities for all researchers

A doubling of public funding of medical research in Europe within the next ten years – to a minimum of 0.25% of gross domestic product (GDP)

Notes for editor
Professor Marja Makarow, Chief Executive European Science Foundation
Professor Liselotte Højgaard, EMRC Chair. Director Clinical Physiology, Nuclear medicine & PET, University of Copenhagen
What is ESF?
The European Science Foundation (ESF) was established in 1974 to create a common European platform for cross-border cooperation in all aspects of scientific research.

With its emphasis on a multidisciplinary and pan-European approach, the Foundation provides the leadership necessary to open new frontiers in European science.

Its activities include providing science policy advice (Science Strategy); stimulating co-operation between researchers and organisations to explore new directions (Science Synergy); and the administration of externally funded programmes (Science Management). These take place in the following areas: Physical and engineering sciences; Medical sciences; Life, earth and environmental sciences; Humanities; Social sciences; Polar; Marine; Space; Radio astronomy frequencies; Nuclear physics.

Headquartered in Strasbourg with offices in Brussels and Ostend the ESF’s membership comprises 77 national funding agencies, research performing agencies and academies from 30 European nations.

The Foundation’s independence allows the ESF to objectively represent the priorities of all these members.

What is EMRC?
The European Medical Research Councils (EMRC) is the European Science Foundation’s membership organisation for all medical research councils in Europe. The mission of the EMRC is to promote innovative medical research and its clinical application towards improved human health. EMRC offers authoritative strategic advice for science policy making, research management, ethics, and better health services. In its activities, EMRC serves as a voice of its Member Organisations and the European scientific community. EMRC disseminates knowledge and promotes the socio-economic value of medical research to the general public and the decision makers.

Press contact:

Sofia Valleley
European Science Foundation
1 Quai Lezay Marnésia – BP 90015
67080 Strasbourg cedex (FR)
+33 388 76 71 49
svalleley@esf.org
Science contact:
EMRC Chair
Professor Liselotte Højgaard, MD DMSc
Director, professor
1Clinical Physiology, Nuclear medicine & PET
Rigshospitalet - University of Copenhagen (DK)
+45 3545 4215 or +45 3545 1792
liselotte.hoejgaard@rh.regionh.dk

Thomas Lau | alfa
Further information:
http://www.esf.org/emrc/whitepaper

More articles from Science Education:

nachricht Starting school boosts development
11.05.2017 | Max-Planck-Institut für Bildungsforschung

nachricht New Master’s programme: University of Kaiserslautern educates experts in quantum technology
15.03.2017 | Technische Universität Kaiserslautern

All articles from Science Education >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Salmonella as a tumour medication

HZI researchers developed a bacterial strain that can be used in cancer therapy

Salmonellae are dangerous pathogens that enter the body via contaminated food and can cause severe infections. But these bacteria are also known to target...

Im Focus: Neutron star merger directly observed for the first time

University of Maryland researchers contribute to historic detection of gravitational waves and light created by event

On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...

Im Focus: Breaking: the first light from two neutron stars merging

Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.

Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

3rd Symposium on Driving Simulation

23.10.2017 | Event News

ASEAN Member States discuss the future role of renewable energy

17.10.2017 | Event News

World Health Summit 2017: International experts set the course for the future of Global Health

10.10.2017 | Event News

 
Latest News

Microfluidics probe 'cholesterol' of the oil industry

23.10.2017 | Life Sciences

Gamma rays will reach beyond the limits of light

23.10.2017 | Physics and Astronomy

The end of pneumonia? New vaccine offers hope

23.10.2017 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>